Skip to main content
. 2017 May 10;2017:3454212. doi: 10.1155/2017/3454212

Figure 1.

Figure 1

CysLTs in neurodegenerative diseases. The circle shows the changes of the CysLT pathway components grouped for the different neurodegenerative diseases and observed in human patients and in in vitro/in vivo models.